Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 147

1.

Data to model risks for recolonizing wolves in Scandinavia through the integration of territory presence and human-driven mortalities.

Recio MR, Zimmermann B, Wikenros C, Zetterberg A, Wabakken P, Sand H.

Data Brief. 2018 Aug 28;20:686-690. doi: 10.1016/j.dib.2018.08.060. eCollection 2018 Oct.

2.

A molecular pathology method for sequential fluorescence in situ hybridization for multi-gene analysis at the single-cell level.

Hu L, Yin X, Sun J, Zetterberg A, Miao W, Cheng T.

Oncotarget. 2016 Jun 23;8(31):50534-50541. doi: 10.18632/oncotarget.10245. eCollection 2017 Aug 1.

3.

Identification of characteristic and prognostic values of chromosome 1p abnormality by multi-gene fluorescence in situ hybridization in multiple myeloma.

Li F, Hu L, Xu Y, Li Z, Yi S, Gu Z, Li C, Hao M, Ru K, Zhan F, Zetterberg A, Yuan W, Cheng T, Qiu L.

Leukemia. 2016 May;30(5):1197-201. doi: 10.1038/leu.2015.254. Epub 2015 Sep 16. No abstract available.

PMID:
26460211
4.

A standardized method for quantifying proliferation by Ki-67 and cyclin A immunohistochemistry in breast cancer.

Mu K, Li L, Yang Q, Yun H, Kharaziha P, Ye DW, Auer G, Lagercrantz SB, Zetterberg A.

Ann Diagn Pathol. 2015 Aug;19(4):243-8. doi: 10.1016/j.anndiagpath.2015.05.002. Epub 2015 May 12.

PMID:
26049669
5.

Epidermal growth factor receptor and AKT1 gene copy numbers by multi-gene fluorescence in situ hybridization impact on prognosis in breast cancer.

Li J, Su W, Zhang S, Hu Y, Liu J, Zhang X, Bai J, Yuan W, Hu L, Cheng T, Zetterberg A, Lei Z, Zhang J.

Cancer Sci. 2015 May;106(5):642-9. doi: 10.1111/cas.12637. Epub 2015 Mar 16.

6.

Quantitative multigene FISH on breast carcinomas identifies der(1;16)(q10;p10) as an early event in luminal A tumors.

Rye IH, Lundin P, Månér S, Fjelldal R, Naume B, Wigler M, Hicks J, Børresen-Dale AL, Zetterberg A, Russnes HG.

Genes Chromosomes Cancer. 2015 Apr;54(4):235-48. doi: 10.1002/gcc.22237. Epub 2014 Dec 26.

7.

Multi-gene fluorescence in situ hybridization to detect cell cycle gene copy number aberrations in young breast cancer patients.

Li C, Bai J, Hao X, Zhang S, Hu Y, Zhang X, Yuan W, Hu L, Cheng T, Zetterberg A, Lee MH, Zhang J.

Cell Cycle. 2014;13(8):1299-305. doi: 10.4161/cc.28201. Epub 2014 Feb 28.

8.

Prostate biopsy sampling causes hematogenous dissemination of epithelial cellular material.

Ladjevardi S, Auer G, Castro J, Ericsson C, Zetterberg A, Häggman M, Wiksell H, Jorulf H.

Dis Markers. 2014;2014:707529. doi: 10.1155/2014/707529. Epub 2014 Jan 28.

9.

Fluorescence in situ hybridization (FISH): an increasingly demanded tool for biomarker research and personalized medicine.

Hu L, Ru K, Zhang L, Huang Y, Zhu X, Liu H, Zetterberg A, Cheng T, Miao W.

Biomark Res. 2014 Feb 5;2(1):3. doi: 10.1186/2050-7771-2-3.

10.

QM-FISH analysis of the genes involved in the G1/S checkpoint signaling pathway in triple-negative breast cancer.

Zhang S, Shao Y, Hou G, Bai J, Yuan W, Hu L, Cheng T, Zetterberg A, Zhang J.

Tumour Biol. 2014 Mar;35(3):1847-54. doi: 10.1007/s13277-013-1246-5. Epub 2013 Oct 5.

PMID:
24096545
11.

RAD51 can inhibit PDGF-B-induced gliomagenesis and genomic instability.

Westermark UK, Lindberg N, Roswall P, Bråsäter D, Helgadottir HR, Hede SM, Zetterberg A, Jasin M, Nistér M, Uhrbom L.

Neuro Oncol. 2011 Dec;13(12):1277-87. doi: 10.1093/neuonc/nor131. Epub 2011 Sep 16.

12.

Allele-specific copy number analysis of tumors.

Van Loo P, Nordgard SH, Lingjærde OC, Russnes HG, Rye IH, Sun W, Weigman VJ, Marynen P, Zetterberg A, Naume B, Perou CM, Børresen-Dale AL, Kristensen VN.

Proc Natl Acad Sci U S A. 2010 Sep 28;107(39):16910-5. doi: 10.1073/pnas.1009843107. Epub 2010 Sep 13.

13.

Genomic architecture characterizes tumor progression paths and fate in breast cancer patients.

Russnes HG, Vollan HKM, Lingjærde OC, Krasnitz A, Lundin P, Naume B, Sørlie T, Borgen E, Rye IH, Langerød A, Chin SF, Teschendorff AE, Stephens PJ, Månér S, Schlichting E, Baumbusch LO, Kåresen R, Stratton MP, Wigler M, Caldas C, Zetterberg A, Hicks J, Børresen-Dale AL.

Sci Transl Med. 2010 Jun 30;2(38):38ra47. doi: 10.1126/scitranslmed.3000611.

14.

Inferring tumor progression from genomic heterogeneity.

Navin N, Krasnitz A, Rodgers L, Cook K, Meth J, Kendall J, Riggs M, Eberling Y, Troge J, Grubor V, Levy D, Lundin P, Månér S, Zetterberg A, Hicks J, Wigler M.

Genome Res. 2010 Jan;20(1):68-80. doi: 10.1101/gr.099622.109. Epub 2009 Nov 10.

15.

Genomic instability and proliferative activity as risk factors for distant metastases in breast cancer.

Li L, Mu K, Zhou G, Lan L, Auer G, Zetterberg A.

Br J Cancer. 2008 Aug 5;99(3):513-9. doi: 10.1038/sj.bjc.6604479.

16.

Aberrant expression of cyclin E in low-risk node negative breast cancer.

Ahlin C, Gruhne B, Holmqvist M, Zetterberg A, Fjällskog ML.

Acta Oncol. 2008;47(8):1539-45. doi: 10.1080/02841860701856581.

PMID:
18607847
17.

Long-term immunosuppression in burned patients assessed by in vitro neutrophil oxidative burst (Phagoburst).

Parment K, Zetterberg A, Ernerudh J, Bakteman K, Steinwall I, Sjoberg F.

Burns. 2007 Nov;33(7):865-71. Epub 2007 May 29.

PMID:
17537580
18.

Novel patterns of genome rearrangement and their association with survival in breast cancer.

Hicks J, Krasnitz A, Lakshmi B, Navin NE, Riggs M, Leibu E, Esposito D, Alexander J, Troge J, Grubor V, Yoon S, Wigler M, Ye K, Børresen-Dale AL, Naume B, Schlicting E, Norton L, Hägerström T, Skoog L, Auer G, Månér S, Lundin P, Zetterberg A.

Genome Res. 2006 Dec;16(12):1465-79.

19.

Genomic instability and prognosis in breast carcinomas.

Kronenwett U, Ploner A, Zetterberg A, Bergh J, Hall P, Auer G, Pawitan Y.

Cancer Epidemiol Biomarkers Prev. 2006 Sep;15(9):1630-5.

20.

High-resolution ROMA CGH and FISH analysis of aneuploid and diploid breast tumors.

Hicks J, Muthuswamy L, Krasnitz A, Navin N, Riggs M, Grubor V, Esposito D, Alexander J, Troge J, Wigler M, Maner S, Lundin P, Zetterberg A.

Cold Spring Harb Symp Quant Biol. 2005;70:51-63.

PMID:
16869738
21.

PROBER: oligonucleotide FISH probe design software.

Navin N, Grubor V, Hicks J, Leibu E, Thomas E, Troge J, Riggs M, Lundin P, Månér S, Sebat J, Zetterberg A, Wigler M.

Bioinformatics. 2006 Oct 1;22(19):2437-8. Epub 2006 Jun 1.

PMID:
16740623
22.

Parallel cyclin E and cyclin A expression in neoplastic lesions of the uterine cervix.

Erlandsson F, Martinsson-Ahlzén HS, Wallin KL, Hellström AC, Andersson S, Zetterberg A.

Br J Cancer. 2006 Apr 10;94(7):1045-50.

23.

Separase: a universal trigger for sister chromatid disjunction but not chromosome cycle progression.

Wirth KG, Wutz G, Kudo NR, Desdouets C, Zetterberg A, Taghybeeglu S, Seznec J, Ducos GM, Ricci R, Firnberg N, Peters JM, Nasmyth K.

J Cell Biol. 2006 Mar 13;172(6):847-60.

24.

Synthesis of 8-aminoadenosine 5'-(aminoalkyl phosphates), analogues of aminoacyl adenylates.

Yousefi-Salakdeh E, Murtola M, Zetterberg A, Yeheskiely E, Strömberg R.

Bioorg Med Chem. 2006 Apr 15;14(8):2653-9. Epub 2005 Dec 20.

PMID:
16368242
25.

Single cell analysis of G1 check points-the relationship between the restriction point and phosphorylation of pRb.

Martinsson HS, Starborg M, Erlandsson F, Zetterberg A.

Exp Cell Res. 2005 May 1;305(2):383-91.

PMID:
15817163
26.

Changes in cell shape and anchorage in relation to the restriction point.

Martinsson HS, Zickert P, Starborg M, Larsson O, Zetterberg A.

J Cell Physiol. 2005 Apr;203(1):27-34.

PMID:
15534858
27.

Developmental context determines latency of MYC-induced tumorigenesis.

Beer S, Zetterberg A, Ihrie RA, McTaggart RA, Yang Q, Bradon N, Arvanitis C, Attardi LD, Feng S, Ruebner B, Cardiff RD, Felsher DW.

PLoS Biol. 2004 Nov;2(11):e332. Epub 2004 Sep 28.

28.

Molecular cytogenetic characterization shows higher genetic homogeneity in conventional renal cell carcinoma compared to other kidney cancers.

Alimov A, Sundelin B, Bergerheim U, Pavlenko M, Pisa P, Zetterberg A, Larsson C, Lagercrantz S.

Int J Oncol. 2004 Oct;25(4):955-60.

PMID:
15375545
29.

Large-scale copy number polymorphism in the human genome.

Sebat J, Lakshmi B, Troge J, Alexander J, Young J, Lundin P, Månér S, Massa H, Walker M, Chi M, Navin N, Lucito R, Healy J, Hicks J, Ye K, Reiner A, Gilliam TC, Trask B, Patterson N, Zetterberg A, Wigler M.

Science. 2004 Jul 23;305(5683):525-8.

30.

Deregulation of cyclin E in human cells interferes with prereplication complex assembly.

Ekholm-Reed S, Méndez J, Tedesco D, Zetterberg A, Stillman B, Reed SI.

J Cell Biol. 2004 Jun 21;165(6):789-800. Epub 2004 Jun 14.

31.

Improved grading of breast adenocarcinomas based on genomic instability.

Kronenwett U, Huwendiek S, Ostring C, Portwood N, Roblick UJ, Pawitan Y, Alaiya A, Sennerstam R, Zetterberg A, Auer G.

Cancer Res. 2004 Feb 1;64(3):904-9.

32.

Mutation of hCDC4 leads to cell cycle deregulation of cyclin E in cancer.

Ekholm-Reed S, Spruck CH, Sangfelt O, van Drogen F, Mueller-Holzner E, Widschwendter M, Zetterberg A, Reed SI.

Cancer Res. 2004 Feb 1;64(3):795-800. Erratum in: Cancer Res. 2004 Apr 15;64(8):2939. Reed, Susanna Ekholm [corrected to Reed-Ekholm, Susanna].

33.

DNA amplifications and aneuploidy, high proliferative activity and impaired cell cycle control characterize breast carcinomas with poor prognosis.

Blegen H, Will JS, Ghadimi BM, Nash HP, Zetterberg A, Auer G, Ried T.

Anal Cell Pathol. 2003;25(3):103-14.

34.

Abnormal expression pattern of cyclin E in tumour cells.

Erlandsson F, Wählby C, Ekholm-Reed S, Hellström AC, Bengtsson E, Zetterberg A.

Int J Cancer. 2003 Apr 10;104(3):369-75.

35.

Genetic alterations in cervical carcinomas: frequent low-level amplifications of oncogenes are associated with human papillomavirus infection.

Zhang A, Månér S, Betz R, Angström T, Stendahl U, Bergman F, Zetterberg A, Wallin KL.

Int J Cancer. 2002 Oct 10;101(5):427-33.

36.

Amplification of the telomerase reverse transcriptase (hTERT) gene in cervical carcinomas.

Zhang A, Zheng C, Hou M, Lindvall C, Wallin KL, Angström T, Yang X, Hellström AC, Blennow E, Björkholm M, Zetterberg A, Gruber A, Xu D.

Genes Chromosomes Cancer. 2002 Jul;34(3):269-75.

PMID:
12007187
37.

The histone deacetylase inhibitor trichostatin A derepresses the telomerase reverse transcriptase (hTERT) gene in human cells.

Hou M, Wang X, Popov N, Zhang A, Zhao X, Zhou R, Zetterberg A, Björkholm M, Henriksson M, Gruber A, Xu D.

Exp Cell Res. 2002 Mar 10;274(1):25-34.

PMID:
11855854
38.

Sequential immunofluorescence staining and image analysis for detection of large numbers of antigens in individual cell nuclei.

Wählby C, Erlandsson F, Bengtsson E, Zetterberg A.

Cytometry. 2002 Jan 1;47(1):32-41.

PMID:
11774347
39.

[Hartwell, Hunt and Nurse share the 2001 Nobel Prize in physiology or medicine. CDK and cyclin--molecular motors of cell cycle].

Zetterberg AH, Pettersson RF, Lindahl SG.

Lakartidningen. 2001 Oct 17;98(42):4544-50. Swedish. No abstract available.

PMID:
11715224
40.

Genetic instability promotes the acquisition of chromosomal imbalances in T1b and T1c breast adenocarcinomas.

Blegen H, Ghadimi BM, Jauho A, Zetterberg A, Eriksson E, Auer G, Ried T.

Anal Cell Pathol. 2001;22(3):123-31.

41.

Frequent co-amplification of two different regions on 17q in aneuploid breast carcinomas.

Latham C, Zhang A, Nalbanti A, Månér S, Zickert P, Blegen H, Zetterberg A.

Cancer Genet Cytogenet. 2001 May;127(1):16-23.

PMID:
11408059
42.

Accumulation of cyclin E is not a prerequisite for passage through the restriction point.

Ekholm SV, Zickert P, Reed SI, Zetterberg A.

Mol Cell Biol. 2001 May;21(9):3256-65.

43.

Frequent amplification of the telomerase reverse transcriptase gene in human tumors.

Zhang A, Zheng C, Lindvall C, Hou M, Ekedahl J, Lewensohn R, Yan Z, Yang X, Henriksson M, Blennow E, Nordenskjöld M, Zetterberg A, Björkholm M, Gruber A, Xu D.

Cancer Res. 2000 Nov 15;60(22):6230-5.

44.

Overexpression of MYC causes p53-dependent G2 arrest of normal fibroblasts.

Felsher DW, Zetterberg A, Zhu J, Tlsty T, Bishop JM.

Proc Natl Acad Sci U S A. 2000 Sep 12;97(19):10544-8.

45.

A detailed analysis of cyclin A accumulation at the G(1)/S border in normal and transformed cells.

Erlandsson F, Linnman C, Ekholm S, Bengtsson E, Zetterberg A.

Exp Cell Res. 2000 Aug 25;259(1):86-95.

PMID:
10942581
46.

Analysis of mechanisms and frequency of CDKN2A/B gene loss during progression of RAS-transformed rat embryo fibroblast clones.

Zhou JN, Hashemi J, Helou K, Zhang A, Röhme D, Zetterberg A, Levan G, Linder S.

Somat Cell Mol Genet. 1998 Nov;24(6):327-39.

PMID:
10763411
47.

Reliability and significance of DNA measurements in interphase nuclei and division figures in histological sections.

Steinbeck RG, Auer GU, Zetterberg AD.

Eur J Cancer. 1999 May;35(5):787-95.

PMID:
10505041
48.

Molecular characterization of a tissue-polypeptide-specific-antigen epitope and its relationship to human cytokeratin 18.

Rydlander L, Ziegler E, Bergman T, Schöberl E, Steiner G, Bergman AC, Zetterberg A, Marberger M, Björklund P, Skern T, Einarsson R, Jörnvall H.

Eur J Biochem. 1996 Oct 15;241(2):309-14.

49.

Near tetraploid prostate carcinoma. Methodologic and prognostic aspects.

Forsslund G, Nilsson B, Zetterberg A.

Cancer. 1996 Oct 15;78(8):1748-55.

PMID:
8859188
50.

Relationship between oncogene amplification, aneuploidy and altered expression of p53 in breast cancer.

Latham C, Maner S, Blegen H, Eriksson E, Zickert P, Auer G, Zetterberg A.

Int J Oncol. 1996 Feb;8(2):359-65.

PMID:
21544369

Supplemental Content

Loading ...
Support Center